Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells

FEBS Letters

Volumn 586, Issue 11, 2012, Pages 1645-1651

  Schütz, Anke K ^a   Hennes, Thomas ^a   Jumpertz, Sandra ^a   Fuchs, Simone ^a   Bernhagen, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

COP9 signalosome; CSN5; Cullin RING ubiquitin ligase; MIF; p53; Protein degradation

Indexed keywords

BETA CATENIN; CASPASE 3; COP9 SIGNALOSOME; SMALL INTERFERING RNA; WNT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY;

APOPTOSIS; BETA CATENIN; CACO-2 CELLS; CASPASE 3; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDE HYDROLASES; PROTEOLYSIS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84861626169     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.04.037     Document Type: Article

References (58)

1. D.A. Chamovitz, N. Wei, M.T. Osterlund, A.G. von Arnim, J.M. Staub, M. Matsui, and X.W. Deng The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch Cell 86 1996 115 121
2. N. Wei, and X.W. Deng The COP9 signalosome Annu. Rev. Cell Dev. Biol. 19 2003 261 286
3. B. Kapelari, D. Bech-Otschir, R. Hegerl, R. Schade, R. Dumdey, and W. Dubiel Electron microscopy and subunit-subunit interaction studies reveal a first architecture of COP9 signalosome J. Mol. Biol. 300 2000 1169 1178
4. N. Wei, G. Serino, and X.W. Deng The COP9 signalosome: more than a protease Trends Biochem. Sci. 33 2008 592 600
5. M. Sharon, H. Mao, E. Boeri Erba, E. Stephens, N. Zheng, and C.V. Robinson Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality Structure 17 2009 31 40
6. K. Tomoda The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex J. Biol. Chem. 277 2002 2302 2310
7. D. Bech-Otschir, M. Seeger, and W. Dubiel The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis J. Cell Sci. 115 2002 467 473
8. J.-y. Kato, and N. Yoneda-Kato Mammalian COP9 signalosome Genes Cells 14 2009 1209 1225
9. M. Panattoni Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development J. Exp. Med. 205 2008 465 477
10. K. Tomoda, N. Yoneda-Kato, A. Fukumoto, S. Yamanaka, and J.Y. Kato Multiple functions of Jab1 are required for early embryonic development and growth potential in mice J. Biol. Chem. 279 2004 43013 43018
11. D.A. Chamovitz, and D. Segal JAB1/CSN5 and the COP9 signalosome. A complex situation EMBO Rep. 2 2001 96 101
12. G.A. Cope, and RJ. Deshaies COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases Cell 114 2003 663 671
13. D.A. Wolf, C. Zhou, and S. Wee The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat. Cell Biol. 5 2003 1029 1033
14. K. Schweitzer, P.M. Bozko, W. Dubiel, and M. Naumann CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha EMBO J. 26 2007 1532 1541
15. D.A. Chamovitz Revisiting the COP9 signalosome as a transcriptional regulator EMBO Rep. 10 2009 352 358
16. L. Orel, H. Neumeier, K. Hochrainer, B.R. Binder, and J.A. Schmid Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome J. Cell. Mol. Med. 14 2010 1555 1568
17. F.-X. Claret, M. Hibi, S. Dhut, T. Toda, and M. Karin A new group of conserved coactivators that increase the specificity of AP-1 transcription factors Nature 383 1996 453 457
18. K. Tomoda, Y. Kubota, and J. Kato Degradation of the cyclin-dependent- kinase inhibitor p27Kip1 is instigated by Jab1 Nature 398 1999 160 165
19. W. Oh, E.W. Lee, Y.H. Sung, M.R. Yang, J. Ghim, H.W. Lee, and J. Song Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2 J. Biol. Chem. 281 2006 17457 17465
20. A.S. Adler, M. Lin, H. Horlings, D.S. Nuyten, MJ. van de Vijver, and H.Y. Chang Genetic regulators of large-scale transcriptional signatures in cancer Nat. Genet. 38 2006 421 430
21. K. Tomoda, J.Y. Kato, E. Tatsumi, T. Takahashi, Y. Matsuo, and N. Yoneda-Kato The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression Blood 105 2005 775 783
22. M.A. Kouvaraki, G.Z. Rassidakis, L. Tian, R. Kumar, C. Kittas, and F.X. Claret Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1) Cancer Res. 63 2003 2977 2981
23. A. Fukumoto Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer Oncol. Rep. 11 2004 277 284
24. L. Sui, Y. Dong, M. Ohno, Y. Watanabe, K. Sugimoto, Y. Tai, and M. Tokuda Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors Clin. Cancer Res. 7 2001 4130 4135
25. M.A. Patil Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis 26 2005 2050 2057
26. S. Shintani, C. Li, M. Mihara, S. Hino, K. Nakashiro, and H. Hamakawa Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas Oncology 65 2003 355 362
27. S. Denti, M.E. Fernandez-Sanchez, L. Rogge, and E. Bianchi The COP9 signalosome regulates Skp2 levels and proliferation of human cells J. Biol. Chem. 281 2006 32188 32196
28. D. Bech-Otschir, R. Kraft, X. Huang, P. Henklein, B. Kapelari, C. Pollmann, and W. Dubiel COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system EMBO J. 20 2001 1630 1639
29. X.-C. Zhang, 1. Chen, C.-H. Su, H.-Y. Yang, and M.-H. Lee Roles for CSN5 in control of p53/MDM2 activities J. Cell. Biochem. 103 2008 1219 1230
30. X. Huang, C. Langelotz, B.K. Hetfeld-Pechoc, W. Schwenk, and W. Dubiel The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15 J. Mol. Biol. 391 2009 691 702
31. A. Walther, E. Johnstone, C. Swanton, R. Midgley, I. Tomlinson, and D. Kerr Genetic prognostic and predictive markers in colorectal cancer Nat. Rev. Cancer 9 2009 489 499
32. T. Tanaka Colorectal carcinogenesis: review of human and experimental animal studies J. Carcinog. 8 2009 5
33. R.A. Phelps A two-step model for colon adenoma initiation and progression caused by APC loss Cell 137 2009 623 634
34. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
35. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
36. H. Aberle, A. Bauer, J. Stappert, A. Kispert, and R. Kemler Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J. 16 1997 3797 3804
37. P. Polakis Casein kinase 1: a Wnt'er of disconnect Curr. Biol. 12 2002 R499 R501
38. M. Hart The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell Curr. Biol. 9 1999 207 210
39. B.C. Kim Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation Mol. Cell Biol. 24 2004 2251 2262
40. A.S. Adler, L.E. Littlepage, M. Lin, T.L. Kawahara, D.J. Wong, Z. Werb, and H.Y. Chang CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression Cancer Res. 68 2008 506 515
41. U.N. Verma, R.M. Surabhi, A. Schmaltieg, C. Becerra, and R.B. Gaynor Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells Clin. Cancer Res. 9 2003 1291 1300
42. J. Yang, W. Zhang, P.M. Evans, X. Chen, X. He, and C. Liu Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells J. Biol. Chem. 281 2006 11151-11151
43. FJ. Esteva Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer Clin. Cancer Res. 9 2003 5652 5659
44. M.C. Hsu, C.C. Huang, H.C. Chang, T.H. Hu, and W.C. Hung Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor {gamma} ligands in vitro and in vivo Clin. Cancer Res. 14 2008 4045 4052
45. A. Goto Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma Pathol. Int. 54 2004 675 681
46. M. Mori, N. Yoneda-Kato, A. Yoshida, and J.Y. Kato Stable form of JAB1 enhances proliferation and maintenance of hematopoietic progenitors J. Biol. Chem. 283 2008 29011 29021
47. J. Huang, H. Yuan, C. Lu, X. Liu, X. Cao, and M. Wan Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex J. Mol. Biol. 371 2007 514 527
48. J.H. Xiao Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway J. Biol. Chem. 278 2003 29954 29962
49. J.P. Berg Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma Hum. Pathol. 38 2007 1621 1627
50. M.A. Kouvaraki Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma Cancer Res. 66 2006 8581 8589
51. R. Kleemann Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 Nature 408 2000 211 216
52. J.M. Wilson Macrophage migration inhibitory factor promotes intestinal tumorigenesis Gastroenterology 129 2005 1485 1503
53. R. Schulz, N.D. Marchenko, L. Holembowski, G. Fingerle-Rowson, M. Pesic, L. Zender, M. Dobbelstein, and U.M. Moll Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression J. Exp. Med. 209 2012 275 289
54. A. Fukumoto, K. Tomoda, N. Yoneda-Kato, Y. Nakajima, and J.Y. Kato Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines FEBS Lett. 580 2006 5836 5844
55. G. Davidson, and C. Niehrs Emerging links between CDK cell cycle regulators and Wnt signaling Trends Cell Biol. 20 2010 453 460
56. V. Muncan Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc Mol. Cell Biol. 26 2006 8418 8426
57. P. Juin, A.O. Hueber, T. Littlewood, and G. Evan c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release Genes Dev. 13 1999 1367 1381
58. J. Klefstrom, E.W. Verschuren, and G. Evan c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway J. Biol. Chem. 277 2002 43224 43232